ATE242631T1 - Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit - Google Patents

Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit

Info

Publication number: ATE242631T1
Authority: AT; Austria
Prior art keywords: risperidone; transdermal administration; controlled rate; controlled; rate
Prior art date: 1995-04-06

Application number

AT96908146T

Other languages

English (en)

Inventor

Jean Louis Mesens

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-06

Filing date

1996-03-29

Publication date

2003-06-15

1996-03-29 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE242631T1 publication Critical patent/ATE242631T1/de

Links

RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title 1
229960001534 risperidone Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT96908146T 1995-04-06 1996-03-29 Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit ATE242631T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP95200867		1995-04-06
PCT/EP1996/001421 WO1996031201A1 (en)	1995-04-06	1996-03-29	Rate-controlled transdermal administration of risperidone

Publications (1)

Publication Number	Publication Date
ATE242631T1 true ATE242631T1 (de)	2003-06-15

Family

ID=8220172

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96908146T ATE242631T1 (de)	1995-04-06	1996-03-29	Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit

Country Status (16)

Country	Link
EP (1)	EP0879051B9 (de)
JP (1)	JPH11503138A (de)
KR (1)	KR100437672B1 (de)
AR (1)	AR003413A1 (de)
AT (1)	ATE242631T1 (de)
CA (1)	CA2214420A1 (de)
CY (1)	CY2388B1 (de)
DE (1)	DE69628672T2 (de)
DK (1)	DK0879051T3 (de)
ES (1)	ES2201176T3 (de)
HR (1)	HRP960154A2 (de)
IL (1)	IL117809A (de)
PT (1)	PT879051E (de)
TW (1)	TW592729B (de)
WO (1)	WO1996031201A1 (de)
ZA (1)	ZA962752B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10042412B4 (de) *	2000-08-30	2005-12-22	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20050232995A1 (en)	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
DE602005010812D1 (de) *	2004-11-22	2008-12-18	Hisamitsu Pharmaceutical Co	Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
JP4914826B2 (ja) *	2005-02-28	2012-04-11	久光製薬株式会社	経皮吸収製剤
WO2007035942A2 (en) *	2005-09-23	2007-03-29	Alza Corporation	Transdermal risperidone delivery system
AU2007255724B2 (en)	2006-06-09	2012-05-10	Dainippon Sumitomo Pharma Co., Ltd.	Novel tape preparation
DE102007006244B4 (de)	2007-02-08	2012-03-15	Lts Lohmann Therapie-Systeme Ag	Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
EP2230911A4 (de) *	2007-12-21	2013-07-03	Zars Pharma Inc	Patches, Formulierungen und entsprechende Verfahren für die perkutane Applikation von Alprazolam und anderen Arzeneimitteln
JPWO2010098261A1 (ja) *	2009-02-24	2012-08-30	久光製薬株式会社	リスペリドン含有経皮吸収型製剤及びこれを用いた貼付剤
JP2025528758A (ja) *	2023-01-04	2025-09-02	新領医薬技術（深▲せん▼）有限公司	リスペリドン経皮投与システム及びその製造方法と用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3854480A (en) *	1969-04-01	1974-12-17	Alza Corp	Drug-delivery system
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4710191A (en) *	1985-12-16	1987-12-01	Jonergin, Inc.	Therapeutic device for the administration of medicaments
US4938759A (en) *	1986-09-02	1990-07-03	Alza Corporation	Transdermal delivery device having a rate controlling adhesive
US5788983A (en) *	1989-04-03	1998-08-04	Rutgers, The State University Of New Jersey	Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
WO1991002527A1 (en) *	1989-08-21	1991-03-07	Beth Israel Hospital Association	Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists

1996
- 1996-03-22 TW TW085103448A patent/TW592729B/zh not_active IP Right Cessation
- 1996-03-29 JP JP8529968A patent/JPH11503138A/ja active Pending
- 1996-03-29 ES ES96908146T patent/ES2201176T3/es not_active Expired - Lifetime
- 1996-03-29 AT AT96908146T patent/ATE242631T1/de not_active IP Right Cessation
- 1996-03-29 KR KR1019970706213A patent/KR100437672B1/ko not_active Expired - Fee Related
- 1996-03-29 DE DE69628672T patent/DE69628672T2/de not_active Expired - Lifetime
- 1996-03-29 PT PT96908146T patent/PT879051E/pt unknown
- 1996-03-29 EP EP96908146A patent/EP0879051B9/de not_active Expired - Lifetime
- 1996-03-29 DK DK96908146T patent/DK0879051T3/da active
- 1996-03-29 CA CA002214420A patent/CA2214420A1/en not_active Abandoned
- 1996-03-29 WO PCT/EP1996/001421 patent/WO1996031201A1/en not_active Ceased
- 1996-04-02 HR HR95.200.867.0A patent/HRP960154A2/hr not_active Application Discontinuation
- 1996-04-03 AR ARP960102078A patent/AR003413A1/es active IP Right Grant
- 1996-04-03 IL IL11780996A patent/IL117809A/xx not_active IP Right Cessation
- 1996-04-04 ZA ZA9602752A patent/ZA962752B/xx unknown
2003
- 2003-11-04 CY CY0300076A patent/CY2388B1/xx unknown

Also Published As

Publication number	Publication date
CY2388B1 (en)	2004-09-10
AR003413A1 (es)	1998-08-05
HRP960154A2 (en)	1997-08-31
ZA962752B (en)	1997-10-06
JPH11503138A (ja)	1999-03-23
EP0879051A1 (de)	1998-11-25
WO1996031201A1 (en)	1996-10-10
ES2201176T3 (es)	2004-03-16
IL117809A0 (en)	1996-08-04
AU696789B2 (en)	1998-09-17
TW592729B (en)	2004-06-21
DK0879051T3 (da)	2003-09-29
AU5149296A (en)	1996-10-23
EP0879051B9 (de)	2004-03-03
KR100437672B1 (ko)	2004-09-10
PT879051E (pt)	2003-10-31
HK1015681A1 (en)	1999-10-22
EP0879051B1 (de)	2003-06-11
DE69628672D1 (de)	2003-07-17
IL117809A (en)	2000-10-31
DE69628672T2 (de)	2004-04-29
CA2214420A1 (en)	1996-10-10

Legal Events

Date

Code

Title

Description

2004-02-15

UEP

Publication of translation of european patent specification

Ref document number: 0879051

Country of ref document: EP

2008-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE241350T1 (de)	2003-06-15	Transdermale verabreichungsform von flurbiprofen
DE69622780D1 (de)	2002-09-12	Transdermales therapeutisches System mit kontrollierter Wirkstofffreisetzung
FI945311L (fi)	1994-11-11	Oksibutyniinin transdermaalinen annostelu
ZA928011B (en)	1993-06-23	Transdermal administration of melatonin.
DK42093D0 (da)	1993-04-07	Administrationsmetode
DE69218932D1 (de)	1997-05-15	Transdermale therapeutische Formulierung
DE69203990D1 (de)	1995-09-14	Einrichtung zur transdermalen Verabreichung von Medikamenten.
DE69113205D1 (de)	1995-10-26	Transdermales therapeutisches System.
KR950703383A (ko)	1995-09-20	초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
FI913248A0 (fi)	1991-07-04	Kontrollerat frigoerande fast farmaceutisk doseringsform.
IT1284049B1 (it)	1998-05-08	Medicamento per somministrazione nasale
FI943018A7 (fi)	1994-06-22	Terapeuttisia aineita
FI955259L (fi)	1995-11-30	Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
FI942011L (fi)	1994-04-29	Kiteytymisenestoaineita sisältäviä transdermaalisia terapeuttisia järjestelmiä
FI972542L (fi)	1997-06-16	Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
FI952204A7 (fi)	1995-05-08	Terapeuttisia aineita
FI951419A7 (fi)	1995-03-24	Siirtomenetelmä ihonläpäisevien terapeuttisten järjestelmien valmistamiseksi
FI962220L (fi)	1996-06-27	Transdermaalinen terapeuttinen järjestelmä
FI955260L (fi)	1995-11-17	Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antamista varten
DE69330826D1 (de)	2001-10-31	Ozonfreundliche korrekturflüssigkeit
FI943020A7 (fi)	1994-06-22	Terapeuttisia aineita
DE69628672D1 (de)	2003-07-17	Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit
FI924724A7 (fi)	1992-10-19	Parannettu menetelmä lääkkeen antamiseksi iontoforeesilla
ZA966842B (en)	1998-02-16	Transdermal administration of vorozole.
DK101197A (da)	1997-09-05	Medikament til behandling af thrombocytopenia